No evidence of increased risk for Coronavirus Disease 2019 (COVID‐19) in patients treated with Dupilumab for atopic dermatitis in a high‐epidemic area – Bergamo, Lombardy, Italy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2020-09, Vol.34 (9), p.e433-e434
Hauptverfasser:	Carugno, A., Raponi, F., Locatelli, A.G., Vezzoli, P., Gambini, D.M., Di Mercurio, M., Robustelli Test, E., Sena, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibodies, Monoclonal, Humanized - immunology Antibodies, Monoclonal, Humanized - therapeutic use Covid‐19 Special Forum Dermatitis, Atopic - drug therapy Female Humans Interleukin-4 Receptor alpha Subunit - immunology Italy - epidemiology Letter To The Editor Male Middle Aged Risk Factors Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!